Summary
We have used single-strand conformation polymorphism (SSCP) analysis to screen for mutations in the BCL10 gene in 81 primary prostate carcinomas, 20 squamous cell cancers of the head and neck, 15 small-cell lung cancer cell lines, 24 renal carcinoma cell lines and 13 sarcoma cell lines. We failed to find evidence of somatically acquired mutations of the BCL10 gene suggesting that BCL10 does not play a major role in the development of these malignancies.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anglard, P., Trahan, E., Liu, S., Latif, F., Merino, M. J., Lerman, M. I., Zbar, B. & Linehan, W. M. (1992). Molecular and cellular characterisation of human renal cell carcinoma cell lines. Cancer Res 52: 348–356.
Clark, J., Lu, Y. J., Sidhar, S. K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W. M., Shipley, J. & Cooper, C. S. (1997). Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15: 2233–2239.
Condie, A., Eeles, R., Borreson, A. L., Coles, C., Cooper, C. & Prosser, J. (1993). Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis and hydroxylamine and osmium tetroxide techniques. Hum Mutat 2: 58–66.
D’Amico, A. V., Whittington, R., Malkowicz, B., Schultz, D., Blank, K., Broderick, G. A., Tomaszewski, J. E., Renshaw, A. A., Kaplan, I., Beard, C. J. & Wein, A. (1998). Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localised prostate cancer. JAMA 280: 969–974.
Garvin, A. J., Stanley, W. S., Bennett, D. D., Sullivan, J. L. & Sens, D. A. (1986). The in vitro growth, heterotransplanation and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol 125: 208–217.
Hoffman, K., Bucher, P. & Tschopp, J. (1997). The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 22: 155–156.
Kinzler, K. W. & Vogelstein, B. (1997). Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761
Koseki, T., Inohara, N., Chen, S., Carrio, R., Merino, J., Hottiger, M. O., Nabel, G. J. & Nunez, G. (1999). CIPER, a novel NF κB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem 274: 9955–9961.
Lane, D. P. (1992). p53, guardian of the genome. Nature 358: 15–16.
Macintosh, C. A., Stower, M., Reid, N. & Maitland, N. J. (1998). Precise microdissection of human prostate cancer reveals genetic heterogeneity. Cancer Res 58: 23–28.
Matolcsy, A., Casali, P., Warnke, R. A. & Knowles, D. M. (1996). Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated BCL-2 gene. Blood 88: 3937–3944.
Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B. H., Knowles, D. M., Offit, K., Chaganti, R. S. & Dalla-Fevera, R. (1995). Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphomas. Proc Natl Acad Sci USA 92: 12520–12524.
Nojima, T., Wang, Y-S, Abe, S., Matsuna, T., Yanawaki, S. & Nagashina, K. (1990). Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol Jap 40: 487–493.
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press
Sidhar, S. K., Clark, J., Gill, S., Hamoudi, R., Crew, A. J., Gwilliam, R., Ross, M., Linehan, W. M., Birdsall, S., Shipley, J. & Cooper, C. S. (1996). The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Molecular Genet 5: 1333–1338.
Sonobe, H., Manabe, Y., Furihata, M., Iwata, J., Oka, T., Ohtsuki, Y., Mizobuchi, H., Yamamoto, K., Kumano, O. & Abe, S. (1992). Establishment and characterisation of a new human synovial sarcoma cell line HS-SY-II. Lab Invest 67: 498–505.
Thome, M., Martinon, F., Hofmann, K., Rubio, V., Steiner, V., Schneider, P., Mattmann, C. & Tschopp, J. (1999). Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-κB transcription factor and c-Jun N-terminal kinase. J Biol Chem 274: 9962–9968.
Vogelstein, B. & Kinzler, K. W. (1993). The multistep nature of cancer. Trends Genet 9: 138–141.
Willis, T. G., Jadayel, D. M., Du, M-Q, Peng, H., Perry, A., Abdul-Rauf, M., Price, H., Karran, L., Majekodunmi, O., Wlodarska, I., Pan, L., Crook, T., Hamoudi, R., Isaacson, P. & Dyer, M. J. S. (1999). BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96: 35–45.
Yan, M., Lee, J., Schilbach, S., Goddard, A. & Dixit, V. (1999). mE10, a novel caspase recruitment domain containing proapoptotic molecule. J Biol Chem 274(15): 10287–10292.
Yaoita, S., Ohoi, R., Hayashi, Y., Kuwabara, E. & Watanabe, T. (1989). Establishment and characterisation of TN-2 cell line from a neuroblastoma of the left adrenal gland (in Japanese). Hum Cell 2: 199
Zhang, Q., Siebert, R., Yan, M., Hinzmann, B., Cui, X., Xue, L., Rakestraw, K. M., Naeve, C. W., Beckmann, G., Weisenberger, D. D., Sanger, W. G., Nowotny, H., Vesely, M., Callet-Bauchu, E., Salles, G., Dixit, V. M., Rosenthal, A., Schlegelberger, B. & Morris, S. W. (1999). Inactivating mutations and overexpression of BCL10, a caspase recruitment domain (CARD)-containing gene in MALT lymphoma with t(1;14)(p22;q32). Nature Genet 22: 63–68.
Author information
Authors and Affiliations
Consortia
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gill, S., Broni, J., Jefferies, S. et al. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. Br J Cancer 80, 1565–1568 (1999). https://doi.org/10.1038/sj.bjc.6690561
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690561
Keywords
This article is cited by
-
Dysregulation of apoptosis genes in hematopoietic malignancies
Oncogene (2002)
-
Low Frequency ofBCL10 Gene Mutations in B-Cell Non-Hodgkin’s Lymphoma
International Journal of Hematology (2001)
-
BCL10 gene mutations rarely occur in lymphoid malignancies
Leukemia (2000)
-
BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma
Leukemia (2000)
